| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 14, 2023 | Sell(S) | 9K | $19.96 | $170K | 491K |
| Feb 13, 2023 | Sell(S) | 3K | $20.42 | $68K | 500K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001725160-23-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Zentalis Pharmaceuticals, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.